首頁 > 市場調查報告書 > 製藥

精神疾病

市場調查報告書

商品編碼

2084667

生理節律睡眠障礙市場：依治療方法、應用、通路、藥物、最終用戶和地區分類。

Circadian Rhythm Sleep Disorders Market, By Treatment Type, By Application Type, By Distribution Channel, By Drug, By End User, By Geography

出版日期: 2026年06月04日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

據估計，生理節律睡眠障礙市場在2026年將達到27億美元，預計2033年將達到42.3億美元。預計從2026年到2033年，該市場將以6.8%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	27億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	6.80%	2033年市場規模預測：	42.3億美元

睡眠市場正經歷著顯著的變革，其主要驅動力在於人們對睡眠健康的日益關注、診斷能力的提升以及對有效時間療法需求的成長。生理節律睡眠障礙障礙，例如睡眠相位後移症候群、睡眠相位提前症候群和非24小時睡眠-覺醒週期紊亂，會擾亂自然的睡眠-覺醒週期，若不及時治療，可能導致認知能力下降、情緒障礙和代謝功能障礙等嚴重併發症。該市場涵蓋多種治療方案，包括光療、褪黑素受體促效劑、行為療法、聯合治療以及輔助護理產品。

醫療專業人員越來越重視早期診斷和標靶治療，以恢復晝夜節律調節並預防復發。穿戴式睡眠追蹤器、活動記錄器和家庭多導睡眠圖的進步提高了病例檢出的準確性，尤其是在睡眠專科診所資源有限的地區。此外，聯合治療的日益普及有助於最佳化睡眠時間和質量，從而改善治療效果並降低復發風險。

市場動態

由於睡眠-覺醒節律紊亂和生活方式相關的晝夜節律紊亂等疾病的盛行率不斷上升，生理節律睡眠障礙市場正經歷著顯著的成長勢頭。市場成長的主要驅動力是輪班工作者、青少年和老年人等睡眠不足和代謝併發症高風險族群對針對性治療性介入的需求日益成長。時間生理時鐘療法、光療設備和行為療法在疾病管理中發揮核心作用，有助於減輕白天過度嗜睡、情緒障礙和認知障礙等症狀。對早期診斷、個人化治療的日益重視以及意識提升，進一步增強了對可靠的生理節律睡眠障礙解決方案的需求。

睡眠醫學基礎設施的不斷改善正在推動市場成長。這主要得益於穿戴式睡眠監測設備和遠端醫療諮詢的普及，以及褪黑素促效劑、雷美替胺、他西美替胺和Agomelatine等處方藥的日益普及。藥物治療與行為療法的聯合應用能夠改善晝夜節律調節，並降低復發風險。

人們對最佳化睡眠健康的需求日益成長，也推動了市場擴張。睡眠診所、醫院、研究機構和健康中心在識別和管理睡眠障礙方面發揮著至關重要的作用。隨著人們對晝夜節律健康意識的提高，預計市場將受益於患者用藥依從性的改善、臨床療效的提升以及更安全、更有針對性的睡眠障礙治療方法的開發。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數創建了生理節律睡眠障礙市場主要公司的概況：公司概況、產品系列、主要亮點、財務表現和策略。
本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份「生理節律睡眠障礙市場」報告的目標受群眾外包括產業內的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用分析生理節律睡眠障礙市場中使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第10章競爭格局

熱圖分析
市佔率分析
公司簡介
- Vanda Pharmaceuticals
- Aeroflow, Inc.
- Cephalon, Inc.
- Takeda Pharmaceutical Company
- Teva Pharmaceutical Industries Ltd.
- Mylan NV
- The Sunbox Company
- Verilux, Inc.
- Northern Light Technologies
- Koninklijke Philips NV
- Amjo Corp.
分析師意見

第11章

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI4806

Circadian Rhythm Sleep Disorders Market is estimated to be valued at USD 2.7 Bn in 2026 and is expected to reach USD 4.23 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.8% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 2.7 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	6.80%	2033 Value Projection:	USD 4.23 Bn

The market is undergoing a major transformation mainly driven by rising awareness of sleep health, improved diagnostic capabilities, and growing demand for effective chronotherapy treatments. Circadian rhythm sleep disorders, including delayed sleep phase disorder, advanced sleep phase disorder, and non-24-hour sleep-wake disorder, disrupt the natural sleep-wake cycle and may lead to severe complications like impaired cognitive performance, mood disorders, and metabolic dysfunction if left untreated. The market includes a wide array of treatment options like light therapy, melatonin receptor agonists, behavioral interventions, combination therapies, and supportive care products.

Healthcare providers are increasingly focusing on early diagnosis and targeted treatment to restore circadian alignment and prevent recurrence. The advancements in wearable sleep trackers, actigraphy, and home-based polysomnography are improving case detection, especially in regions with limited access to specialized sleep clinics. In addition, the growing use of combination therapy helps optimize sleep timing and quality, thereby improving treatment outcomes and lowering relapse risk.

Market Dynamics

The Circadian Rhythm Sleep Disorders Market is witnessing a major momentum owing to the rising prevalence of sleep-wake misalignment disorders and lifestyle-induced circadian disruptions. The market's growth is largely attributed to the growing need for targeted therapeutic interventions, especially in shift workers, adolescents, and elderly populations who face higher risks of sleep deprivation and metabolic complications. Chronobiotic medications, light therapy devices, and behavioral sleep interventions play a central role in disorder management, thereby helping reduce symptoms like excessive daytime sleepiness, mood disturbances, and cognitive impairments. The rising focus on early diagnosis, personalized treatment, and public awareness is strengthening the demand for reliable Circadian Rhythm Sleep Disorders solutions.

The expansion of sleep medicine infrastructure is fueling market growth. This is mainly driven by the increasing adoption of wearable sleep monitoring, telemedicine-based consultations, and wider availability of prescription therapies like melatonin agonists, ramelteon, tasimelteon, and agomelatine. Combination approaches involving pharmacological and behavioral strategies improve circadian alignment and reduce relapse risk.

The rising demand for optimized sleep health is also propelling the market. Sleep clinics, hospitals, research institutions, and wellness centers play a crucial role in identifying and managing sleep disorders. As awareness of circadian health grows, the market is expected to benefit from better patient adherence, improved clinical outcomes, and the development of safer, more targeted sleep disorder therapies.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the Circadian Rhythm Sleep Disorders Market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Vanda Pharmaceuticals, Aeroflow, Inc., Cephalon, Inc., Takeda Pharmaceutical Company, Teva Pharmaceutical Industries Ltd., Mylan N.V., The Sunbox Company, Verilux, Inc., Northern Light Technologies, Koninklijke Philips N.V., and Amjo Corp.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The Circadian Rhythm Sleep Disorders Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Circadian Rhythm Sleep Disorders Market

Market Segmentation

Treatment Type Insights (Revenue, USD Bn, 2026-2033)
Healthy Lifestyle Changes
Bright Light Therapy
Melatonin
Application Type Insights (Revenue, USD Bn, 2026-2033)
Delayed Sleep Phase Disorder
Advanced Sleep Phase Disorder
Jet Lag
Shift Work Disorder
Irregular Sleep Wake Rhythm
Non-24-hour Sleep-wake Syndrome
Distribution Channel Insights (Revenue, USD Bn, 2026-2033)
Institutional Sales
Retail Sales
Drug Insights (Revenue, USD Bn, 2026-2033)
Melatonin
Modafinil
Tasimelteon
End User Insights (Revenue, USD Bn, 2026-2033)
Hospitals
Home Care Settings
Sleep Centers
Regional Insights (Revenue, USD Bn, 2026 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- U.K.
- Germany
- Italy
- France
- Russia
- Spain
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
Middle East
- GCC
- Israel
- Rest of Middle East
Africa
- North Africa
- Central Africa
- South Africa
Key Players Insights
Vanda Pharmaceuticals
Aeroflow, Inc.
Cephalon, Inc.
Takeda Pharmaceutical Company
Teva Pharmaceutical Industries Ltd.
Mylan N.V.
The Sunbox Company
Verilux, Inc.
Northern Light Technologies
Koninklijke Philips N.V.
Amjo Corp.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Treatment Type
- Market Snapshot, By Application Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Drug
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Product Approval
Collaboration/Merge/Acquisition
Regulatory Landscape
PEST Analysis
Porter's Five Forces Analysis
Epidemiology
Robust Pipeline Analysis

4. Global Circadian Rhythm Sleep Disorders Market, By Treatment Type, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Healthy Lifestyle Changes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Bright Light Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Melatonin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

5. Global Circadian Rhythm Sleep Disorders Market, By Application Type, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Delayed Sleep Phase Disorder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Advanced Sleep Phase Disorder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Jet Lag
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Shift Work Disorder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Irregular Sleep Wake Rhythm
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Non-24-hour Sleep-wake Syndrome
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

6. Global Circadian Rhythm Sleep Disorders Market, By Distribution Channel, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Institutional Sales
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Retail Sales
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

7. Global Circadian Rhythm Sleep Disorders Market, By Drug, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Melatonin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Modafinil
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Tasimelteon
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

8. Global Circadian Rhythm Sleep Disorders Market, By End User, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Home Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Sleep Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

9. Global Circadian Rhythm Sleep Disorders Market, By Region, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Billion)
  - North Africa
  - Central Africa
  - South Africa

10. Competitive Landscape

Heat Map Analysis
Market Share Analysis
Company Profile
- Vanda Pharmaceuticals
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Aeroflow, Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Cephalon, Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Takeda Pharmaceutical Company
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Teva Pharmaceutical Industries Ltd.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Mylan N.V.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- The Sunbox Company
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Verilux, Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Northern Light Technologies
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Koninklijke Philips N.V.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Amjo Corp.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
Analyst Views